3-hydroxy-N-phenylnaphthalene-2-carboxamide

We are 3-hydroxy-N-phenylnaphthalene-2-carboxamide CAS:92-77-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 3-hydroxy-N-phenylnaphthalene-2-carboxamide
CAS.NO:92-77-3
Synonyms:Naphthol AS Supra;Azonaphtol A;3-Hydroxy-2-naphthanilide;2-hydroxy-3-phenylcarbamoylnaphthalene;Amarthol AS
Molecular Formula:C17H13NO2
Molecular Weight:263.29100
 
Physical and Chemical Properties:
Density:1.31 g/cm3
Boiling point:494ºC
Melting point:246-248 °C(lit.)
Flash point:190.7ºC
Index of Refraction:1.632
 
Specification:
Appearance:Rice white powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:An intermediate for organic pigments.
 

3-hydroxy-N-phenylnaphthalene-2-carboxamide


Related News: This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.Ácido dibenzotiofeno-2-borónico CAS:668983-97-9 DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.1-Benzhydrylazetidin-3-amine DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.6-carboxi-4-metil-2-propilbencimidazol CAS:152628-03-0 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.

Related Products
Product Name
4-Iodoanisole Cas:696-62-8 View Details
3-cyclohexenecarboxylic acid Cas:4771-80-6 View Details
4-(Trifluoromethylthio)phenol View Details
17-Acetyl-10,13-dimethyl-6,7,8,10,12,13,14,15octahydro-cyclopenta[a]phenathren-3 Cas:117048-56-3 manufacturer Ruthenium on alumina powder, reduced Cas:7440-18-8 manufacturer 4-(6-methacryloyloxyhexyloxy)phenol Cas:142627-92-7 manufacturer thiouracil manufacturer 2-[(4-chloro-2-nitrophenyl)diazenyl]-3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide manufacturer